July 19, 2021

N4 Pharma MTAs demonstrate commercial interest (Analyst Interview)

N4 Pharma plc (LON:N4P) is the topic of conversation when SP Angel Analyst Vadim Alexandre joins DirectorsTalk. Vadim talks us through the main points of their latest research note, explains..

AstraZeneca’s Imfinzi approved in China for extensive-stage SCLC

AstraZeneca plc (LON:AZN) Imfinzi (durvalumab) has been approved in China for the 1st-line treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC), in combination with standard of care..

Poolbeg Pharma IPO and funds raised provide strong platform to begin rapid growth plan

Poolbeg Pharma (LON:POLB), a clinical stage infectious disease pharmaceutical company with a capital light clinical model, is pleased to announce that admission of its entire issued share capital to trading..

Flutter Entertainment completes debt re-financing transaction

Flutter Entertainment plc (LON:FLTR) has announced that it has completed a debt re-financing transaction that will reduce its effective cost of debt and provide it with additional liquidity, enhancing the..

Jarvis Securities an excellent set of interim results (Interview)

Jarvis Securities plc (LON:JIM) Finance Director Jolyon Head joins DirectorsTalk Interviews to discuss Interim Results for the Six Months Ended 30 June 2021. Jolyon shares his thoughts on the results,..

Renold reports very strong cash generation (Interview)

Renold plc (LON:RNO) CEO Robert Purcell joins DirectorsTalk Interview to discuss its results for the year ended 31 March 2021. Robert talks us through the main highlights, explains how the..

Union Jack Oil Carbon Intensity Study on the Biscathorpe

Union Jack Oil plc (AIM:UJO), a UK focused onshore hydrocarbon production, development and exploration company, is pleased to publish the positive conclusions of a Carbon Intensity Study on the Biscathorpe hydrocarbon project,..

Search

Funds

July 19, 2021

Search

Funds

July 19, 2021

FTSE 100

Funds